Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 152

Results For "INST"

3147 News Found

DKSH and Biolin Scientific extend partnership in the APAC region
News | August 09, 2023

DKSH and Biolin Scientific extend partnership in the APAC region

DKSH has further fortified its strategic partnership with Biolin Scientific, a globally recognized pioneer in surface science instrumentation, across nine key markets in the APAC region


Lonza launches nebula absorbance reader for streamlined Endotoxin and Pyrogen testing
Digitisation | August 09, 2023

Lonza launches nebula absorbance reader for streamlined Endotoxin and Pyrogen testing

The instrument is fully integrated with Lonza’s latest WinKQCLSoftware to enable data integrity compliance, streamline training, and reduce validation burden


Altana acquires ultrasound metrology company Imaginant
News | August 09, 2023

Altana acquires ultrasound metrology company Imaginant

Imaginant offers a unique measurement capability through its PELT coating thickness gauges


Hikal posts Q1 FY 24 consolidated PAT at Rs. 6.92 Cr
News | August 09, 2023

Hikal posts Q1 FY 24 consolidated PAT at Rs. 6.92 Cr

US FDA approval is in line with de-risking strategy for additional API site to service our global customer base


Govt. passes National Dental Commission Bill, 2023
Policy | August 09, 2023

Govt. passes National Dental Commission Bill, 2023

The National Dental Commission Act 2023, will introduce a groundbreaking regulatory framework by establishing the National Dental Commission


Parliament passes National Nursing and Midwifery Commission (NNMC) Bill, 2023
Policy | August 09, 2023

Parliament passes National Nursing and Midwifery Commission (NNMC) Bill, 2023

Several crucial provisions to elevate the standards of nursing education and services, enhance professional conduct, and ensure greater transparency and accountability introduced


KIMS posts Q1 FY24 consolidated PAT at Rs. 80.81 Cr
News | August 08, 2023

KIMS posts Q1 FY24 consolidated PAT at Rs. 80.81 Cr

KIMS has reported total income of Rs. 609.14 crores during the period ended June 30, 2023


Torrent Pharmaceuticals posts Q1 FY 24 consolidated PAT at Rs. 378 Cr
News | August 08, 2023

Torrent Pharmaceuticals posts Q1 FY 24 consolidated PAT at Rs. 378 Cr

Torrent Pharmaceuticals has reported total income of Rs. 2625 crores during the period ended June 30, 2023